Exploring Patient Preferences for Adjunct-to-Insulin Therapy in Type 1 Diabetes.
Bruce A PerkinsJulio RosenstockJay S SkylerLori M B LaffelDavid Z I CherneyChantal MathieuChristianne PangRichard WoodOna KinduryteJyothis T GeorgeJan MarquardNima SoleymanlouPublished in: Diabetes care (2019)
Low-dose SGLTi profile was the favored adjunct-to-insulin therapy by persons with T1D.